Crossmark

Ulinastatin in the treatment of radiotherapy-induced oral mucositis in locoregionally advanced nasopharyngeal carcinoma: a phase 3 randomized clinical trial

Crossref DOI link: https://doi.org/10.1038/s41467-025-57884-6

Published Online: 2025-03-23

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Xuguang

Wu, Haijun

Lei, Feng

Liu, Zhigang https://orcid.org/0000-0003-4043-3196
Shen, Guanzhu

Hu, Xuefeng

Ye, Yijing

Zhu, Manyi

Huang, Huageng

Chen, Boyu

Huang, Runda

Zhao, Chong https://orcid.org/0000-0003-3271-5783
Miao, Jingjing

Wang, Lin https://orcid.org/0000-0002-9132-0805
License Information

Text and Data Mining valid from 2025-03-23

Version of Record valid from 2025-03-23
More Information

Article History

Received: 15 October 2024

Accepted: 28 February 2025

First Online: 23 March 2025

Competing interests

: The authors declare no competing interests.

: The study was approved by the Ethics Committee of Sun Yat-sen University Cancer Center (B2017-063-01-01) and registered on ClinicalTrials.gov, number NCT03387774.

Document is current

Any future updates will be listed below